AQST·03843E104·US·equity·Healthcare - Drug Manufacturers - Specialty & Generic-13D/G
AQST (AQUESTIVE THERAPEUTICS INC) is held by 89 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($31.2M), RTW INVESTMENTS, LP ($30.8M), FEDERATED HERMES, INC. ($12.2M). Net institutional sentiment: Mixed.
See how AQST's score breaks down across 4 SEC sources
Showing 1-20 of 109
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer